The association of mediastinal mass in the formation of thrombi in pediatric patients with non-lymphoblastic lymphomas.
hematology
hemostasis and thrombosis
lymphoma
non-Hodgkin lymphoma
pediatric hematology/oncology
Journal
Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
13
06
2019
revised:
07
10
2019
accepted:
10
10
2019
pubmed:
19
11
2019
medline:
23
4
2020
entrez:
19
11
2019
Statut:
ppublish
Résumé
Children diagnosed with cancer are at a significantly higher risk of developing a thrombotic event (TE) compared with the general population. The rarity of these events makes it difficult to discern the specific risk factors; however, age, sex, presence of central venous lines, inherited thrombophilia, and mediastinal mass may play a role. The primary aim of this study is to identify prognostic characteristics of children diagnosed with non-lymphoblastic lymphomas associated with a greater risk of developing a TE early on in their disease, with an increased focus on mediastinal mass characteristics. Retrospective chart review of pediatric patients diagnosed with non-lymphoblastic lymphoma between 2004 and 2014 at St. Jude Children's Research Hospital. TE occurred in 8.5% (n = 28/330) of individuals at a median of 21 days from the diagnosis of a non-lymphoblastic lymphoma, with 60% of TEs occurring within 30 days of diagnosis. Of the variables evaluated, only presence of a peripherally inserted central catheter (odds ratio [OR]: 3.14 [95% CI: 1.24-7.98; P = 0.02]) and degree of superior vena cava (SVC) compression of > 25% increased the odds of developing a TE (OR: 2.2 [95% CI: 1.01-4.93; P = 0.048]). Pediatric patients with non-lymphoblastic lymphoma are at increased risk of developing TEs. In contrast to previous studies, the presence of a mediastinal mass alone was not associated with a higher risk of TE, but individuals with a mediastinal mass with 25% or greater degree of SVC compression were more likely to develop a TE. This finding highlights a high-risk group of children who may benefit from prophylactic anticoagulation.
Sections du résumé
BACKGROUND
Children diagnosed with cancer are at a significantly higher risk of developing a thrombotic event (TE) compared with the general population. The rarity of these events makes it difficult to discern the specific risk factors; however, age, sex, presence of central venous lines, inherited thrombophilia, and mediastinal mass may play a role. The primary aim of this study is to identify prognostic characteristics of children diagnosed with non-lymphoblastic lymphomas associated with a greater risk of developing a TE early on in their disease, with an increased focus on mediastinal mass characteristics.
METHODS
Retrospective chart review of pediatric patients diagnosed with non-lymphoblastic lymphoma between 2004 and 2014 at St. Jude Children's Research Hospital.
RESULTS
TE occurred in 8.5% (n = 28/330) of individuals at a median of 21 days from the diagnosis of a non-lymphoblastic lymphoma, with 60% of TEs occurring within 30 days of diagnosis. Of the variables evaluated, only presence of a peripherally inserted central catheter (odds ratio [OR]: 3.14 [95% CI: 1.24-7.98; P = 0.02]) and degree of superior vena cava (SVC) compression of > 25% increased the odds of developing a TE (OR: 2.2 [95% CI: 1.01-4.93; P = 0.048]).
CONCLUSION
Pediatric patients with non-lymphoblastic lymphoma are at increased risk of developing TEs. In contrast to previous studies, the presence of a mediastinal mass alone was not associated with a higher risk of TE, but individuals with a mediastinal mass with 25% or greater degree of SVC compression were more likely to develop a TE. This finding highlights a high-risk group of children who may benefit from prophylactic anticoagulation.
Identifiants
pubmed: 31736198
doi: 10.1002/pbc.28057
pmc: PMC7233458
mid: NIHMS1576095
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e28057Subventions
Organisme : NCI NIH HHS
ID : P30 CA021765
Pays : United States
Organisme : NCI NIH HHS
ID : CA-21765
Pays : United States
Informations de copyright
© 2019 Wiley Periodicals, Inc.
Références
Front Pediatr. 2017 Feb 06;5:12
pubmed: 28220143
Thromb Res. 2017 Apr;152:64-68
pubmed: 28249199
Thromb Res. 2008;122(4):459-65
pubmed: 18237767
Int J Pediatr Obes. 2010 Dec;5(6):458-60
pubmed: 20233144
Thromb Res. 2010 Apr;125 Suppl 2:S151-4
pubmed: 20433996
Blood. 2003 Jun 1;101(11):4273-8
pubmed: 12560228
J Pediatr. 2011 Jul;159(1):133-7
pubmed: 21353248
Thromb Res. 2006;118(1):137-52
pubmed: 16039698
Pediatr Blood Cancer. 2008 Dec;51(6):792-7
pubmed: 18798556
Thromb Res. 2011 Aug;128(2):130-4
pubmed: 21492908